184 related articles for article (PubMed ID: 24211728)
1. Analytical and preanalytical validation of a new mass spectrometric serum 5-hydroxyindoleacetic acid assay as neuroendocrine tumor marker.
Tohmola N; Itkonen O; Sane T; Markkanen H; Joenväärä S; Renkonen R; Hämäläinen E
Clin Chim Acta; 2014 Jan; 428():38-43. PubMed ID: 24211728
[TBL] [Abstract][Full Text] [Related]
2. Preanalytical validation and reference values for a mass spectrometric assay of serum vanillylmandelic acid for screening of catecholamine secreting neuroendocrine tumors.
Tohmola N; Itkonen O; Turpeinen U; Joenväärä S; Renkonen R; Hämäläinen E
Clin Chim Acta; 2015 Jun; 446():206-12. PubMed ID: 25896957
[TBL] [Abstract][Full Text] [Related]
3. Comparison of serum serotonin and serum 5-HIAA LC-MS/MS assays in the diagnosis of serotonin producing neuroendocrine neoplasms: A pilot study.
Lindström M; Tohmola N; Renkonen R; Hämäläinen E; Schalin-Jäntti C; Itkonen O
Clin Chim Acta; 2018 Jul; 482():78-83. PubMed ID: 29596816
[TBL] [Abstract][Full Text] [Related]
4. A single fasting plasma 5-HIAA value correlates with 24-hour urinary 5-HIAA values and other biomarkers in midgut neuroendocrine tumors (NETs).
Tellez MR; Mamikunian G; O'Dorisio TM; Vinik AI; Woltering EA
Pancreas; 2013 Apr; 42(3):405-10. PubMed ID: 23160483
[TBL] [Abstract][Full Text] [Related]
5. Effect of Lanreotide Depot/Autogel on Urinary 5-Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors.
Pavel ME; Phan AT; Wolin EM; Mirakhur B; Liyanage N; Pitman Lowenthal S; Fisher GA; Vinik AI;
Oncologist; 2019 Apr; 24(4):463-474. PubMed ID: 30355775
[TBL] [Abstract][Full Text] [Related]
6. Measurement of plasma 5-hydroxyindole acetic acid by liquid chromatography tandem mass spectrometry--comparison with HPLC methodology.
Miller AG; Brown H; Degg T; Allen K; Keevil BG
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Mar; 878(7-8):695-9. PubMed ID: 20117968
[TBL] [Abstract][Full Text] [Related]
7. Chromogranin A as an alternative to 5-hydroxyindoleacetic acid in the evaluation of symptoms during treatment of patients with neuroendocrine Tumors.
Korse CM; Bonfrer JM; Aaronson NK; Hart AA; Taal BG
Neuroendocrinology; 2009; 89(3):296-301. PubMed ID: 18840995
[TBL] [Abstract][Full Text] [Related]
8. Chromogranin A as a biochemical marker for the management of neuroendocrine tumors: a multicenter study developed in Argentina.
Belli SH; Oneto A; Aranda C; O'Connor JM; Domenichini E; Roca E; Méndez G; Bestani MC; Parma P; Giacomi N; Marmissolle F
Acta Gastroenterol Latinoam; 2009 Sep; 39(3):184-9. PubMed ID: 19845257
[TBL] [Abstract][Full Text] [Related]
9. Online extraction of 5-hydroxyindole acetic acid from urine for analysis by liquid chromatography-tandem mass spectrometry.
Perry H; Keevil B
Ann Clin Biochem; 2008 Mar; 45(Pt 2):149-52. PubMed ID: 18325177
[TBL] [Abstract][Full Text] [Related]
10. HPLC-mass spectrometry method for quantitative detection of neuroendocrine tumor markers: vanillylmandelic acid, homovanillic acid and 5-hydroxyindoleacetic acid.
Lionetto L; Lostia AM; Stigliano A; Cardelli P; Simmaco M
Clin Chim Acta; 2008 Dec; 398(1-2):53-6. PubMed ID: 18760269
[TBL] [Abstract][Full Text] [Related]
11. Urinary 5-HIAA measurement using automated on-line solid-phase extraction-high-performance liquid chromatography-tandem mass spectrometry.
de Jong WH; Graham KS; de Vries EG; Kema IP
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jun; 868(1-2):28-33. PubMed ID: 18482877
[TBL] [Abstract][Full Text] [Related]
12. Transient elevation of serum 5-HIAA by dietary serotonin and distribution of 5-HIAA in serum protein fractions.
Tohmola N; Johansson A; Sane T; Renkonen R; Hämäläinen E; Itkonen O
Ann Clin Biochem; 2015 Jul; 52(Pt 4):428-33. PubMed ID: 25249663
[TBL] [Abstract][Full Text] [Related]
13. A serum and platelet-rich plasma serotonin assay using liquid chromatography tandem mass spectrometry for monitoring of neuroendocrine tumor patients.
Korse CM; Buning-Kager JCGM; Linders TC; Heijboer AC; van den Broek D; Tesselaar MET; van Tellingen O; van Rossum HH
Clin Chim Acta; 2017 Jun; 469():130-135. PubMed ID: 28385629
[TBL] [Abstract][Full Text] [Related]
14. Quantitative Profiling of Platelet-Rich Plasma Indole Markers by Direct-Matrix Derivatization Combined with LC-MS/MS in Patients with Neuroendocrine Tumors.
van Faassen M; Bouma G; de Hosson LD; Peters MAM; Kats-Ugurlu G; de Vries EGE; Walenkamp AME; Kema IP
Clin Chem; 2019 Nov; 65(11):1388-1396. PubMed ID: 31551315
[TBL] [Abstract][Full Text] [Related]
15. Ultrafast LC-MS/MS analysis of 5-hydroxyindoleacetic acid (5-HIAA) in serum.
Oxelbark J; Lövenhamn A
Scand J Clin Lab Invest; 2021 Sep; 81(5):401-405. PubMed ID: 34100674
[TBL] [Abstract][Full Text] [Related]
16. Plasma tryptophan pathway metabolites quantified by liquid chromatography-tandem mass spectrometry as biomarkers in neuroendocrine tumor patients.
Johansen SU; Hansen T; Nordborg A; Meyer R; Goll R; Florholmen J; Jensen E
J Neuroendocrinol; 2024 Mar; 36(3):e13372. PubMed ID: 38361341
[TBL] [Abstract][Full Text] [Related]
17. Alcohol biomarker analysis: simultaneous determination of 5-hydroxytryptophol glucuronide and 5-hydroxyindoleacetic acid by direct injection of urine using ultra-performance liquid chromatography-tandem mass spectrometry.
Stephanson N; Helander A; Beck O
J Mass Spectrom; 2007 Jul; 42(7):940-9. PubMed ID: 17565712
[TBL] [Abstract][Full Text] [Related]
18. Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors.
Bajetta E; Ferrari L; Martinetti A; Celio L; Procopio G; Artale S; Zilembo N; Di Bartolomeo M; Seregni E; Bombardieri E
Cancer; 1999 Sep; 86(5):858-65. PubMed ID: 10463986
[TBL] [Abstract][Full Text] [Related]
19. A reliable and simple method for the assay of neuroendocrine tumor markers in human urine by solid-phase microextraction-gas chromatography-triple quadrupole mass spectrometry.
Monteleone M; Naccarato A; Sindona G; Tagarelli A
Anal Chim Acta; 2013 Jan; 759():66-73. PubMed ID: 23260678
[TBL] [Abstract][Full Text] [Related]
20. Simple method for the quantitative analysis of endogenous folate catabolites p-aminobenzoylglutamate (pABG) and its acetamido (apABG) derivative in human serum and urine by liquid chromatography-tandem mass spectrometry.
Sokoro AA; Etter ML; Lepage J; Weist B; Eichhorst J; Lehotay DC
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 832(1):9-16. PubMed ID: 16427369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
